Inception Digital, a leading provider of video production, interactive visual solutions, broadcast and webcast platforms for virtual meetings and audiovisual/meeting support, announced the launch of a new corporate brand identity and name.

Binary Fountain – the leading online reputation management platform for enterprises, healthcare organizations and small and medium-sized businesses – along with HCA Healthcare and Branch Strategy, will co-present a webinar entitled, “How to Optimize Your Digital Patient Experience.”

A combination of regulatory conditions, shifts in physician workplace demographics, and an increased reliance of highly specialized sales personnel has steadily eroded the traditional sales reps’ responsibilities and ability to manage the HCP practice relationship as a true SPOC.

W2O Sentient announced the appointment of respected industry leaders Dominic Viola as Managing Director, Client Services, and Michael Spitz as Practice Leader, Strategy.

At its core, “Customer experience,” or CX, is shorthand for the relationship between a customer and a company, even if that company is removed from the point of sale. The CX relationship should stretch across all touchpoints both physical and virtual and all media in between. Today’s customers expect companies to know and understand them, creating a seamless experience across the entire customer-company relationship.

Just 27 percent of physicians say they find pharma websites to be a credible source of professional information, according to a recent survey by Manhattan Research.

W2O Group announced that veteran biopharma executive John H. Johnson and healthcare marketing and communications leader Charlene Prounis have joined its board of directors.

Introducing mobile into the patient engagement journey is one way that brands can drive efficiencies across three key areas.

Havas Group announced that Havas Health becomes Havas Health & You. The new entity joins together the agencies of Havas Health with the consumer health marketing communications practices across Havas companies around the world.

“Failing to plan is planning to fail” states time management guru Alan Lakein. Nowhere does this axiom ring more true than in the tightly controlled world of Rx launches. Given the time and expense required to bring a prescription drug to market, coupled with its limited exclusive lifespan, we must maximize every moment from market conditioning to loss of exclusivity (LOE).